AIT Guidelines – Allergic Asthma Feedback
Allergen Immunotherapy (AIT) Guidelines are important for the management of allergic diseases. The AIT Guidelines will be presented in two sections, Part 1; systematic reviews and Part 2; practical recommendations. As a significant step in the creation of the Part 2 AIT Guidelines, chapter 4, Allergic Asthma is now available for review until 25 June 2017. We encourage you to submit feedback and thank you for your input.
Visit the AIT Guideline submissions here.
Visit the AIT Guideline submissions here.
EAACI Food Allergy Training Course – Abstract submission closing soon
This training course aims to provide a broad overview of current state-of-the-art practices in preventing and treating food allergy. The course will be hosted at the University of Manchester, United Kingdom, from 14 -16 September 2017. The abstract submission is open until 30 June 2017 at 24:00 CET.
There will be a limited number of 120 places.
Visit the website here
There will be a limited number of 120 places.
Visit the website here
EAACI Master Class on Occupational Allergy – Registration is open
The main goal is to review the importance and role of different known and potential biomarkers useful to define the pathophysiological and clinical profiles of patients affected by occupational lung disease, particularly occupational asthma. The course will be hosted at the Hospital La Paz in Madrid, Spain, from 29-30 September 2017.
There will be a limited number of 100 places.
Visit the website here
There will be a limited number of 100 places.
Visit the website here
EAACI recruits new Editors-in-Chief for its journal – Allergy
The European Academy of Allergy and Clinical Immunology (EAACI) is seeking to appoint two co-Editors-in-Chief to succeed Prof. Thomas Bieber and Prof. Hans-Uwe Simon, who will finishing their term as editors of the journal at the end of December 2017.
Allergy (ALL) one of the leading journals in the field of Allergy and Clinical immunology. With an Impact Factor of 6.335 Allergy ranks 2/25 (Allergy) and 21/151 (Immunology). The journal is co-owned by EAACI and John Wiley and Sons A/S and published by John Wiley and Sons, Ltd.
For more information, job description and application details, please click here.
Allergy (ALL) one of the leading journals in the field of Allergy and Clinical immunology. With an Impact Factor of 6.335 Allergy ranks 2/25 (Allergy) and 21/151 (Immunology). The journal is co-owned by EAACI and John Wiley and Sons A/S and published by John Wiley and Sons, Ltd.
For more information, job description and application details, please click here.
Welcome to ISMA 2017
The International Symposium on Molecular Allergology (isma) will take place in Luxembourg on the 9th-11th November 2017.
We are now accepting abstract submissions. For all information surrounding isma, we invite you to view the website.
Find out more and register here
We are now accepting abstract submissions. For all information surrounding isma, we invite you to view the website.
Find out more and register here